Scientific Literature Search

Source record

Opicapone (Ongentys) - a COMT inhibitor for Parkinson's disease.

Check source for author details

Med Lett Drugs Ther · 2021-01-01

PMID: 33646998

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives.

Ahmed LA, Al-Massri KF.

Curr Stem Cell Res Ther · 2021-01-01

DOI: 10.2174/1574888x16666210303151237PMID: 33655876

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Video-Based Analyses of Parkinson's Disease Severity: A Brief Review.

Sibley KG, Girges C, Hoque E, Foltynie T.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202402PMID: 33682727

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

A Long Way to Go: Patient Perspectives on Digital Health for Parkinson's Disease.

Riggare S, Stamford J, Hägglund M.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202408PMID: 33682728

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

The Home-Based Sleep Laboratory.

Hanein Y, Mirelman A.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202412PMID: 33682729

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodríguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202472PMID: 33682731

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Borghammer P.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202481PMID: 33682732

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Advances in Stem Cells Transplantation for the Therapy of Parkinson's Disease.

Zeng X, Geng W, Jia J, Wang Z.

Curr Stem Cell Res Ther · 2021-01-01

DOI: 10.2174/1574888x16666210309153949PMID: 33687901

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies.

Ugale V, Dhote A, Narwade R, Khadse S, Reddy PN, Shirkhedkar A.

CNS Neurol Disord Drug Targets · 2021-01-01

DOI: 10.2174/1871527320666210309141627PMID: 33687902

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Potential of Antibiotics for the Treatment and Management of Parkinson's Disease: An Overview.

Yadav N, Thakur AK, Shekhar N, Ayushi.

Curr Drug Res Rev · 2021-01-01

DOI: 10.2174/2589977513666210315095133PMID: 33719951

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.

Khatir ZZ, Irannejad H.

Mini Rev Med Chem · 2021-01-01

DOI: 10.2174/1389557521666210315163045PMID: 33719962

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

COVID-19 and Parkinson's Disease: What Do We Know So Far?

Artusi CA, Romagnolo A, Ledda C, Zibetti M, Rizzone MG, Montanaro E, Bozzali M, Lopiano L.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-202463PMID: 33749619

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

41.435 articles found

Opicapone (Ongentys) - a COMT inhibitor for Parkinson's disease.

Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives.

Video-Based Analyses of Parkinson's Disease Severity: A Brief Review.

A Long Way to Go: Patient Perspectives on Digital Health for Parkinson's Disease.

The Home-Based Sleep Laboratory.

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Advances in Stem Cells Transplantation for the Therapy of Parkinson's Disease.

GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies.

Potential of Antibiotics for the Treatment and Management of Parkinson's Disease: An Overview.

Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.

COVID-19 and Parkinson's Disease: What Do We Know So Far?

Filters